Transaction expands Canadian pension plan’s direct investment holdings in India, while increasing its global exposure to renewables sector SINGAPORE, July 30, 2021 (GLOBE NEWSWIRE) — OMERS Infrastructure today announced that it has signed a Stock Purchase Agreement to acquire from International Finance Corporation and IFC GIF Investment Company I an
KAYA, BURKINA FASO – The COVID-19 pandemic has led to cuts in foreign aid from donor nations such as Britain, which this month slashed its aid budget by $5.5 billion. The funding loss is being felt in Burkina Faso, where it could shut down a group that…
TOKYO – At age 46, the second-oldest skateboarder at the Tokyo Games is hoping to not have a heart attack and have mounds of fun. Should be no problem. Fun has been a life’s work for Dallas Oberholzer.”I have never had a real job. I have never applied …
Tokyo’s metropolitan government said new coronavirus infections surged to a record high Saturday as the city hosts the Olympic Games.The government reported 4,058 new cases, topping 4,000 for the first time.The new record was set one day after Japan ex…
The following is an extract from the “CNH Industrial 2021 second quarter results” press release. The complete press release can be accessed by visiting the media section of the CNH Industrial corporate website: https://www.cnhindustrial.com/en-us/media/press_releases/Pages/default.aspx or consulting the accompanying PDF: CNH Industrial reports strong second quarter performance. Consolidated revenues of $8.9
Thursday 29 July 2021 TURNOVER INCREASES 26% IN THE FIRST HALF OF 2021 AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid management and mechanisms, has posted consolidated turnover of €487.6m in the first half of 2021, up by 26.0% compared to the first half of the previous […]
SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted its supplemental New Drug Application (sNDA) for toripalimab
